Electrocore, Inc. income statement
In fiscal 2025, Electrocore, Inc. reported revenue of $32.0m, up 27.2% on the year before, operating income of −$13.2m (a -41.1% margin) and net income of −$14.0m, or −$1.65 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 3 | 5 | 9 | 16 | 25 | 32 | 37 |
| Cost of revenue | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 4 | 4 | 5 |
| Gross profit | 0 | 0 | 1 | 2 | 4 | 7 | 13 | 21 | 28 | 32 |
| Research and development | 8 | 12 | 10 | 4 | 3 | 6 | 5 | 2 | 3 | 3 |
| Selling, general and administrative | 18 | 43 | 35 | 22 | 22 | 24 | 27 | 31 | 38 | 43 |
| Operating income | −26 | −55 | −46 | −25 | −20 | −23 | −19 | −12 | −13 | −14 |
| Interest expense | 6 | — | 0 | 0 | — | 0 | — | 0 | 0 | 0 |
| Income before tax | −36 | −56 | −45 | −25 | −18 | −23 | −19 | −12 | −14 | −15 |
| Income tax | — | 0 | 0 | −1 | −1 | −0 | −0 | −0 | 0 | −0 |
| Net income | −36 | −56 | −45 | −24 | −17 | −22 | −19 | −12 | −14 | −15 |
| Diluted EPS | — | −$1.19 | −$23.10 | −$9.00 | −$4.36 | −$4.69 | −$3.42 | −$1.59 | −$1.65 | −$1.66 |
| Diluted shares (average) | — | 29m | 29m | 39m | — | — | 6m | 7m | 8m | 9m |
| EBITDA | −26 | −54 | −46 | −24 | −20 | −22 | −18 | −11 | −13 | −14 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 7 | 7 | 7 | 9 | 9 | 10 | 9 |
| Cost of revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | 5 | 6 | 6 | 6 | 7 | 8 | 8 | 8 |
| Research and development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 8 | 8 | 9 | 9 | 10 | 10 | 13 | 10 |
| Operating income | −3 | −3 | −4 | −4 | −3 | −3 | −5 | −3 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −2 | −3 | −4 | −4 | −3 | −3 | −6 | −3 |
| Income tax | 0 | 0 | −0 | 0 | 0 | 0 | −0 | 0 |
| Net income | −2 | −3 | −4 | −4 | −3 | −3 | −5 | −3 |
| Diluted EPS | −$0.31 | −$0.40 | −$0.47 | −$0.44 | −$0.40 | −$0.34 | −$0.59 | −$0.33 |
| EBITDA | −2 | −3 | −4 | −3 | −3 | −3 | −5 | −3 |
Compare with peers
- Cytosorbents Corp income statement
- Utah Medical Products Inc income statement
- Retractable Technologies Inc income statement
- Orchestra Biomed Holdings, Inc. income statement
- Myomo, Inc. income statement
Head to head: CTSO vs ECORECOR vs UTMDECOR vs RVP
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies